CSIMarket
 


Myriad Genetics Inc   (MYGN)
Other Ticker:  
 

Myriad Genetics Inc 's Quick Ratio

MYGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




MYGN Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Sep 30 2020)
I. Quarter
(Jun 30 2020)
IV. Quarter
(Mar 31 2020)
III. Quarter
Y / Y Current Liabilities Change 128.11 % 29.57 % 9.23 % 7.06 % -6.09 %
Y / Y Cash & cash equivalent Change -9.42 % 24.36 % 12.48 % 59.09 % 21.24 %
Quick Ratio MRQ 0.61 1.18 1.2 1.48 1.53
Overall Ranking # # # # #
Seq. Current Liabilities Change 81.88 % 11.44 % -9.05 % 23.74 % 3.3 %
Seq. Cash & cash equivalent Change -6.64 % 9.79 % -26.35 % 20 % 28.18 %



Quick Ratio second quarter 2021 Comment
Due to increase in Current Liabilities in the second quarter 2021, Quick Ratio fell to 0.61 below Myriad Genetics Inc average.

Within In Vitro & In Vivo Diagnostic Substances industry 205 other companies have achieved higher Quick Ratio than Myriad Genetics Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are MYGN Segments?
See Quick Ratio MYGN on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 206
Healthcare Sector # 794
Overall Market # 2951


Quick Ratio Statistics
High Average Low
7.88 2.46 0.5
(Dec 31 2011)   (Sep 30 2016)




Financial Statements
Myriad Genetics Inc 's Current Liabilities $ 271 Millions Visit MYGN's Balance sheet
Myriad Genetics Inc 's Cash & cash equivalent $ 164 Millions Visit MYGN's Balance sheet
Source of MYGN's Sales Visit MYGN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within In Vitro & In Vivo Diagnostic Substances Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Lantheus Holdings Inc   1.24 $ 91.500  Millions$ 73.826  Millions
Myriad Genetics Inc   0.61 $ 164.400  Millions$ 271.000  Millions
Ortho Clinical Diagnostics Holdings Plc  0.42 $ 200.900  Millions$ 479.200  Millions
Idexx Laboratories Inc  0.38 $ 232.134  Millions$ 610.679  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IMPL's Profile

Stock Price

IMPL's Financials

Business Description

Fundamentals

Charts & Quotes

IMPL's News

Suppliers

IMPL's Competitors

Customers & Markets

Economic Indicators

IMPL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071